Home/Filings/4/0001055726-18-000009
4//SEC Filing

Sardesai Niranjan 4

Accession 0001055726-18-000009

CIK 0001055726other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 6:36 PM ET

Size

14.4 KB

Accession

0001055726-18-000009

Insider Transaction Report

Form 4
Period: 2018-03-09
Sardesai Niranjan
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    2018-03-09$4.51/sh6,896$31,101108,705 total
  • Tax Payment

    Common Stock

    2018-03-10$4.51/sh5,653$25,495123,486 total
  • Exercise/Conversion

    Restricted Stock Unit

    2018-03-1020,43440,866 total
    Common Stock (20,434 underlying)
  • Exercise/Conversion

    Common Stock

    2018-03-10+20,434129,139 total
  • Exercise/Conversion

    Restricted Stock Unit

    2018-03-0925,00025,000 total
    Common Stock (25,000 underlying)
  • Exercise/Conversion

    Common Stock

    2018-03-09+25,000115,601 total
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares vested on March 9, 2018; 25,000 shares will vest on March 9, 2019. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
  • [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
  • [F4]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1
  • filerCIK 0001464547

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:36 PM ET
Size
14.4 KB